adalimumab vs dexamethasone
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of adalimumab and dexamethasone. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Humira
Decadron
Idacio is a medicine that blocks a protein called TNF. It is used to treat several diseases, including arthritis and Crohn's disease.
Dexamethasone (Decadron) is a corticosteroid medicine. It helps reduce inflammation and suppress the immune system.
Idacio can help adults with rheumatoid arthritis by reducing joint pain and damage. It can also help children (2 years and older) with juvenile idiopathic arthritis. Idacio treats psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa and uveitis.
This medicine treats many conditions, including allergies, skin problems, and breathing issues. It can also help with certain cancers, hormone problems, and nervous system disorders. Dexamethasone can also be used for short-term relief of arthritis and other joint problems.
Idacio works by blocking a protein in your body called tumor necrosis factor (TNF). TNF can cause inflammation and damage in certain diseases. By blocking TNF, Idacio can reduce these symptoms.
Dexamethasone works by decreasing inflammation in the body. It also changes how your immune system works. This can help reduce symptoms of various conditions.
- • Infections (like colds or sinus infections)
- • Injection site reactions (redness, itching, pain, or swelling)
- • Headache
- • Rash
- • Increased appetite
- • Weight gain
- • Fluid retention
- • Mood swings
- • Insomnia
- Pain 49,062
- Arthralgia 48,039
- Injection Site Pain 47,251
- Fatigue 39,111
- Rheumatoid Arthritis 35,573
- Fatigue 16,525
- Diarrhoea 16,515
- Plasma Cell Myeloma 13,768
- Nausea 13,495
- Pneumonia 13,291
Idacio can increase your risk of serious infections that could lead to hospitalization or death. Tell your doctor if you have any infections before starting Idacio. Idacio may also increase your risk of certain cancers, including lymphoma. Children and teens taking TNF blockers like Idacio have developed rare, aggressive cancers.
If you have a systemic fungal infection, you should not take this medicine. Long-term use can also make it harder for your body to respond to stress.
Tell your doctor if you are pregnant or plan to become pregnant. Idacio can cross the placenta and may affect your baby's immune system. Talk to your doctor about vaccines for your baby if you took Idacio during pregnancy.
Talk to your doctor if you are pregnant or breastfeeding before taking this medicine. Dexamethasone may harm an unborn baby. It can also pass into breast milk.
Also Compare, Nearby Drugs
Compare adalimumab with
Compare dexamethasone with
How to Read This adalimumab vs dexamethasone Comparison
adalimumab is classified in the TNF-Alpha Inhibitor (Biologic) drug class, while dexamethasone sits within the Corticosteroid class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, adalimumab has 219,036 submissions while dexamethasone has 73,594. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for adalimumab or dexamethasone.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.